Advances in developing ACE2 derivatives against SARS-CoV-2

Extensive immune evasion of SARS-CoV-2 rendered therapeutic antibodies ineffective in the COVID-19 pandemic. Propagating SARS-CoV-2 variants are characterised by immune evasion capacity through key amino acid mutations, but can still bind human angiotensin-converting enzyme 2 (ACE2) through the spik...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haoran, Lv, Panjing, Jiang, Jingrui, Liu, Yahui, Yan, Ruixi, Shu, Sainan, Hu, Bing, Xiao, Han, Cai, Kun, Yuan, Shuai, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019897/
https://www.ncbi.nlm.nih.gov/pubmed/36934742
http://dx.doi.org/10.1016/S2666-5247(23)00011-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019897/
https://www.ncbi.nlm.nih.gov/pubmed/36934742
http://dx.doi.org/10.1016/S2666-5247(23)00011-3

Ejemplares similares